Khanmammadov, N. Et Al. 2024. Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum-Resistant or-Allergic Metastatic Ovarian Cancer. Turk Onkoloji Dergisi , vol.39, no.2 , 176-182.

Khanmammadov, N., Doğan, İ., Okay, N. S., YILDIZ, A., Khishigsuren, B., AZİZY, A., ... Saip, P.(2024). Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum-Resistant or-Allergic Metastatic Ovarian Cancer. Turk Onkoloji Dergisi , vol.39, no.2, 176-182.

Khanmammadov, Nıjat Et Al. "Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum-Resistant or-Allergic Metastatic Ovarian Cancer," Turk Onkoloji Dergisi , vol.39, no.2, 176-182, 2024

Khanmammadov, Nıjat Et Al. "Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum-Resistant or-Allergic Metastatic Ovarian Cancer." Turk Onkoloji Dergisi , vol.39, no.2, pp.176-182, 2024

Khanmammadov, N. Et Al. (2024) . "Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum-Resistant or-Allergic Metastatic Ovarian Cancer." Turk Onkoloji Dergisi , vol.39, no.2, pp.176-182.

@article{article, author={Nıjat KHANMAMMADOV Et Al. }, title={Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum-Resistant or-Allergic Metastatic Ovarian Cancer}, journal={Turk Onkoloji Dergisi}, year=2024, pages={176-182} }